Overexpression of both p185(c-erbB2) and p170(mdr-1) renders breast cancer cells highly resistant to taxol

Oncogene

Volumn 16, Issue 16, 1998, Pages 2087-2094

  Yu, Dihua ^a,b   Liu, Bolin ^a   Jing, Tong ^a   Sun, Dantong ^a   Price, Janet E ^a   Singletary, S Eva ^a   Ibrahim, Nuhad ^a   Hortobagyi, Gabriel N ^a   Hung, Mien Chie ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; HER 2 neu; Oncogene; P glycoprotein; Taxol

Indexed keywords

DOCETAXEL; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; PACLITAXEL; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAXOID;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CELL CULTURE; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; P-GLYCOPROTEIN; PACLITAXEL; RECEPTOR, ERBB-2; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0032559889     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201729     Document Type: Article

References (31)

1. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T. (1986). Science, 232, 1644-1646.
2. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Srawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758-3765.
3. Bacus SS, Stancovski I, Huberman L, Chin D, Hurwitz E, Mills GB, Ullrich A, Sela M and Yarden Y. (1992). Cancer Res., 52, 2580-2589.
4. Bargmann CI, Hung M-C and Weinberg RA. (1986). Nature, 319, 226-230.
5. Berkova N and Page M. (1995). Anticancer Research, 15, 863-866.
6. Chevalier B, Fumoleau P, Kerbrat P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Lentz MA and Van Glabbeke M. (1995). J. of Clin. Oncol., 13, 314-322.
7. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A and Ullrich A. (1985). Science, 230, 1132-1139.
8. Efferth T and Volm M. (1993). Cancer Lett., 70, 197-202.
9. Fojo AT, Shen D-W, Mickley LA, Pastan I and Gottesman MM. (1987). J. Clin. Oncol., 5, 1922.
10. Goldstein LJ, Galski H, Fojo A, Willingham R, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I. (1989). J. Natl. Cancer Inst., 81, 116-124.
11. Gusterson BA, Gelber RD, Coldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Burki K, Castiglione M, Collins J, Lindtner J, Seen H-J and Ludwig IBCSG. (1992). J. Clin. Oncol., 10, 1049-1056.
12. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver LK. (1991) Cancer Res., 51, 4575-4580.
13. Hay R, Caputo J, Chen TR, Macy M, McClintock P and Reid Y, (1992). 7th edition.
14. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK and Hortobagyi GN. (1991). J. Natl. Cancer Inst., 83, 1797-1805.
15. Kraus MH, Popescu NC, Amsbaugh SC and King CR. (1987). EMBO J., 6, 605-610.
16. Lacroix H, Iglehart JD, Skinner MA and Kraus MH. (1989). Oncogene, 4, 145-151.
17. Miller SJ, Suen TC, Sexton TB and Hung MC. (1994). Intl. J. Onc., 4, 599-608.
18. Moscow JA and Cowan KH. (1988). J. Natl. Cancer Inst., 80, 14-20.
19. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). N. Engl. J. Med., 330, 1260-1266.
20. Nooter K and Herweijer H. (1991). Br. J. Cancer, 63, 663.
21. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829-1838.
22. Schneider J, Rubio M-P, Barbazan M-J, Rodriguez-Escudero FJ, Seizinger BR and Castresana JS. (1994). J. Natl. Cancer Inst., 86, 850-855.
23. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
24. Stern DF, Heffernan PA and Weinberg RA. (1986). Mol. Cell. Biol., 6, 1729-1740.
25. Tan M, Yao J and Yu D. (1997). Cancer Res., 57, 1199-1205.
26. Tauchi K, Hori S, Itoh H, Osamura RY, Tokuda Y and Tajima T. (1989). Virchows Arch. A Pathol. Anat. Iliostopathol., 416, 65-73.
27. Tsai CM, Levitzki A, Wu L-H, Chang KT, Chen C-C, Gazit A and Perng RP. (1996). Cancer Res., 56, 1068-1074.
28. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230-234.
29. Yu D, Liu B, Tan M, Li J, Wang S-S and Hung M-C. (1996). Oncogene, 13, 1359-1365.
30. Yu D, Suen T-C, Yan D-H, Chang LS and Hung M-C. (1990). Proc. Natl. Acad. Sci. USA., 87, 4499-4503.
31. Zhang L and Hung M-C. (1996). Oncogene, 12, 571-576.